Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Nov;104(5 Pt 1):922-5.
doi: 10.1097/01.AOG.0000141441.41178.6b.

Botulinum toxin in the treatment of refractory vaginismus

Affiliations

Botulinum toxin in the treatment of refractory vaginismus

Shirin Ghazizadeh et al. Obstet Gynecol. 2004 Nov.

Abstract

Objective: To investigate the efficacy of botulinum toxin injection to treat women with moderate and severe vaginismus.

Methods: Twenty-four women referred to our clinic from February 2002 to February 2004 (mean age 25 years; range 19-34 years) with third- to fourth-degree vaginismus were recruited for this study. These women had previous unsuccessful treatments. Botulinum toxin (150-400 mIU) was injected into the puborectalis muscles in 3 sites on each side of the vagina.

Results: Twenty-three patients (95.8%) had vaginal examinations 1 week postoperatively that showed little or no vaginismus, 18 (75%) achieved satisfactory intercourse after the first injection, 4 (16.7%) had mild pain, 1 was cured after a second injection, 1 patient refused vaginal examination and did not attempt to have coitus, and another had no coitus as a result of her husband's secondary impotence. The women were followed up for a mean of 12.3 months (range 2-24 months), and there were no cases of recurrence.

Conclusion: In refractory cases of vaginismus when conventional therapies have failed, local injection of botulinum toxin can be considered.

Level of evidence: III.

PubMed Disclaimer

Comment in

  • Vulva: the forgotten pelvic organ.
    Noller KL. Noller KL. Obstet Gynecol. 2004 Nov;104(5 Pt 1):913-4. doi: 10.1097/01.AOG.0000146916.08064.fe. Obstet Gynecol. 2004. PMID: 15516377 No abstract available.

Substances